LaVoieHealthScience Continues to Add to Public Company Client Roster

LaVoieHealthScience Continues to Add to Public Company Client Roster

Integrity Applications and Savara Pharmaceuticals Join LHS Portfolio of PR/IR Clients

Boston, MA – November 9, 2017 — LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced two additional public company clients, Integrity Applications and Savara Pharmaceuticals. These clients join a prestigious group of innovative health and science companies that are represented by LHS for their investor and/or public relations solutions.

Integrity Applications (OTCMKTS: IGAP), founded in 2001 and is focused on the design, development, and commercialization of non-invasive glucose monitoring technologies for people with type 2 diabetes and prediabetes. The company has developed GlucoTrack®, a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements in about a minute without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices.

Savara Pharmaceuticals (NASDAQ: SVRA), went public through a reverse merger with Mast Therapeutics in 2017. Based in West Lake Hills, TX, Savara is an emerging pharmaceutical development company focused on advancing a pipeline of novel inhalation therapies for the treatment of patients with rare pulmonary conditions. Savara has three investigational products in various stages of clinical development: Molgradex, the first inhaled product being developed for the treatment of patients with Pulmonary Alveolar Proteinosis and Nontuberculous Mycobacterial (NTM) Lung Infection; AeroVanc, an inhaled dry powder form of vancomycin to treat Methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis patients; and Aironite, which is inhaled via nebulizer to treat heart failure patients with preserved ejection fraction. Savara has an affiliate company based in Hørsholm, Denmark.

“Our integrated public and investor relations offerings, building on our team’s expertise is validated by these new client wins,” said Donna L. LaVoie, President & CEO of LaVoieHealthScience. “Each client has very specific business objectives in which our industry-tested strategic communications programs are being implemented. Aligning with true innovators in the health and science field is our passion.”

About LaVoieHealthScience
LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. In addition to clients listed above, LaVoieHealthScience represents leaders such as Biotechnology Innovation Organization, Fusion Pharmaceuticals, Iota BioSciences, Landos Biopharma, LEO Science Hub, NewLink Genetics, Newron Pharmaceuticals, Origenis, Xontogeny LLC and other emerging health and science companies.

###

Media Contact:
Ryan Donovan
rdonovan@lavoiehealthscience.com
617-374-8800 x102

Multi-Party Communications

Multi-Party Communications: Four Keys for Success

As life science companies continue the trend toward partnerships, communications challenges can multiply.  Partnerships help companies to enter new markets, continue niche research and introduce innovations sooner. But even though they are joining forces, each company will have a unique, and sometimes competing, set of communications and business goals.

While it’s easy to default to the needs of the larger company, strategic communications entails finding ways to balance the needs of all parties.  A solid communications strategy conveys a clear and consistent message to stakeholders of all companies in the partnership, and also paves the way for patients, advocacy groups, media and investors to learn more.

The following are four key issues to consider for multi-party communications:

  • Audience Identification: Ensure that both companies clearly establish the key stakeholders for their news, as well as the appropriate digital, print and broadcast media.
  • Consistent Messaging: While the key messages should be tailored to each company’s audience, the underlying theme must be determined up-front and in conjunction with both parties, to ensure there are no surprises in how each are represented to various stakeholder audiences.
  • Internal Communications: Coordinating among internal parties is key.  The science, strategy and financials must be in internal alignment.  Therefore the process for developing expectations and timelines goes a long way toward ensuring a smooth liftoff.
  • External/Social Media Communications: Develop specialized pitches whenever possible. While based on similar underlying message, the outreach should be tailorable to the varying kinds of media outlets each company seeks to attract.  Identify and train key spokespeople in advance so they are at-the-ready for media outreach.  Consider videos and/or podcasts that may be uploaded to social media, and monitor discussion across both companies’ social channels.

The idea of coordinating communications between partners can be daunting.  But with the right preparation and forethought, it can be an exciting time for a strategic communications program to cultivate trust with each company, and deliver results that meet the needs of all parties.

An in-depth version of this article was featured in O’Dwyer’s October 2017 Healthcare & Medical PR Magazine.

ABCs of 13F Filings

Adding, Balancing and Comparing Insights

As we near 45 days post quarter-end, it’s time to prepare for 13F filings, the stock ownership reports filed by institutional investors. While it is easy enough to access 13F data, the challenge is how to add value by combining market intelligence, company insight and competitor understanding into your 13F analyses. Here are our ABCs for adding, balancing and comparing 13F insights.

Add insight gleaned from market intelligence activities

One of the keys to adding value with market intelligence is to ensure you’ve been capturing investor interactions throughout the quarter.  These notes, ideally one or two sentences about the investor and three to five bullets on topics that were covered, can then be tied to changes in ownership. Perhaps someone with whom you met in January is now initiating a position in the September 13F filing period. Or a position is being trimmed and from the investor database you see the portfolio manager has moved to another firm.  Tying on-the-ground insights with on-line data provides important nuances that add value to the company’s future investor relations activities.

Balance news events

The reasons underlying every investment vary – with decisions driven by a blend of quantitative financial performance and investment thesis, and qualitative announcements and news.  Make sure you pull all the releases from the past quarter and conduct a thorough, unbiased assessment on the impact of these announcements on the investment community.  Understand investors’ perception on the company’s recent news and you’ll have a better idea about what’s happening behind the numbers.

Compare competitive position changes

There are hidden gems in every corner of the 13 filings.  This includes buying and selling of your peer companies’ stock.  Perhaps a shareholder has trimmed a position in your company, and has also trimmed positions in your peers.  Or conversely, has a shareholder trimmed a position in your company but doubled down on a peer?  This type of comparative analysis allows for a 360° view of stock ownership and can be used to target the next generation of shareholder as new investors of competitor companies can be added to your target outreach list.

In sum, by adding insights, balancing news events and comparing peer’s positions, 13F data can move beyond a simple ownership review with added value for ongoing IR activities.

Coordinating Messages When Companies Join Forces

Click the image to read more.

By Donna LaVoie

Life science companies, including big and small pharma, biotech and health technology, continue the trend toward partnerships to research, develop and/or commercialize their innovations, allowing companies to enter new markets, continue niche disease research and development and introduce innovations sooner. Adding to the mix are accelerators and venture firms launching new companies into the health science and technology ecosystem.

Even though they are joining forces, and likely have the same end-goal, each of these companies will have a unique, and sometimes competing, set of communications and business goals. They also may have different priorities on stakeholder mix. While it’s easy to default to the needs of the larger company, strategic communications entails finding ways to balance the needs of all parties in the transaction.

Read more at O’Dwyer’s.

Nothing Succeeds Like… Moderation?

Five Fundamentals on Moderating a Panel

Speaking gigs are a true sign of success. You have been recognized as a key opinion leader in your field and you have been asked to share your knowledge and insight. But what about moderating a panel? This too is an acknowledgement of industry leadership. As such, it is a role for which you should be well prepared to ensure the audience benefits from the combined expertise and experience of the moderator and the panelists. Here are 5 fundamentals for moderating excellence.

Know your panelists: Know your panelists individually and as a group. Don’t just scan through their LinkedIn page – understand what their company does, what their job entails and past experience in the field. Conduct an introductory call with the panelists to pressure test topics and ensure there is a good mix of opinions and insights.

Don’t ask the same question of each panelist: The audience does not want to sit through panelists regurgitating information about the same question. Use your research to help generate questions for specific panelists. Some panelists will have drug development expertise and others will have insights into commercialization. Some will be in markets or indications that overlap, and others will not. Target these overlaps and differences to optimize the questions you ask.

Be an active listener: Take notes. Revisit the most important topics that created great conversation and debate. As a moderator, you can bring another perspective by using a third-party reference. For example, “That’s an interesting point Speaker B just made. However, there’s another school of thought that was covered recently in the media. Speaker A, can you comment?” Of course, as an active listener you can also reinforce a point. “That’s an interesting point Speaker B just made and one that was covered recently in the media. Speaker A, can you comment?” Active listening allows you to engage the audience by challenging some points of view and reinforcing others.

Be a mindful timekeeper: Timekeeping is an important task for the moderator. It is your role to lead an engaging conversation within a pre-specified amount of time. Make sure to save some time at the end for audience questions, but not so much that the onus is on them to keep the session going. And don’t hold the audience hostage beyond the allotted time. Your role is to alert the panelists and the audience as the clock winds down. Be prepared to say, “We have time for one more question.”

Have a closing statement: Having alerted the room that the session is coming to an end, make sure you’ve saved a few minutes for closing remarks. Use the notes that you have taken throughout to leave the audience with 3 – 5 takeaways from the panel discussion. A strong close will ensure the audience leaves with an appreciation for the knowledge and expertise not only of the panelists, but also the moderator.

LaVoieHealthScience Adds Former Analyst & Welcomes New PR & IR Clients

LaVoieHealthScience Adds Former Analyst, Chiara Russo to Its Investor Relations Team

Welcomes New PR & IR Clients to its Roster

…LHS Makes Inc. 5000 List for 4th Time

 

Boston, MA – August 24, 2017 —  LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced that former specialty pharmaceutical analyst, Chiara Russo joined the LHS team as Director, Investor Relations. In addition, LHS announced new clients, the life science accelerator, Xontogeny LLC and electroceutical pioneer, Iota BioSciences.

Ms. Russo joins LHS from Cantor Fitzgerald, LLC, where she was Director, Research Analyst covering various small to mid-cap specialty pharma/biotech companies across a multitude of therapeutic areas leading to a significant industry network.  She has been quoted in many news outlets such as Bloomberg, Reuter, TheStreet and Bezinga and accompanied company executives on numerous non-deal roadshows in major investor centers.  Prior to her role at Cantor, Chiara was Vice President, Research Analyst at Janney Montgomery Scott, LLC, having started her career at Think Equity LLC.

“Continuing to add experienced health and science communications talent to our team is an important part of our strategy for growth,” said Donna L. LaVoie, President & CEO of LaVoieHealthScience. “With our continued focus in providing an integrated solution in both investor and public relations to our clients, adding Chiara to the team provides us with additional bench strength in IR and financial communications.”

“I am excited to already be applying my skills as an analyst to help LHS’ clients with story-telling and their investment thesis along with an insider’ view on how news is viewed and potential institutional targets,” said Russo.

Xontogeny LLC, founded by former Sarepta CEO and serial entrepreneur, Chris Garabedian, is a biotech aggregator that supports the accelerated development of life science technologies in the pursuit of helping patients with serious diseases.  Xontogeny partners with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.

Iota BioSciences, founded in Berkeley, CA, is an emerging electroceutical company revolutionizing the use of “vanishingly small” wireless, battery less sensors, bringing closer a time when a Fitbit-like device could monitor internal nerves, muscles, or organs in real time.

“As this is our fourth time making the Inc. 5000 fastest-growing private company list, we are proud of the team’s accomplishments and to add these clients to our list of movers and shakers in the health and sciences field,” said Donna LaVoie, President & CEO of LaVoieHealthScience. “The LHS team is excited to help these emerging health and science innovators add value and grow.”

About LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. In addition to clients listed above, LaVoieHealthScience represents leaders such as Biotechnology Innovation Organization, Cydan Development, Imara, NewLink Genetics, Newron Pharmaceuticals, Origenis, and other emerging health and science companies.

###

Contact:
Beth Kurth
Vice President, Investor Relations
bkurth@lavoiehealthscience.com
617-374-8800 x106

LaVoieHealthScience Clients Recognized by Xconomy

 LaVoieHealthScience Clients Recognized by Xconomy

LEO Science & Tech Hub and Xontogeny Selected as Award Finalists

LaVoieHealthScience, an integrated investor and public relations agency focused on advancing health and science innovations, today announced that two clients, LEO Science & Tech Hub and Xontogeny are finalists for the 2017 Xconomy awards!  The Xconomy awards honor the top people, companies and organizations that make the Boston life sciences community one of the most vibrant innovation centers in the world during Biotech Week Boston.

Chris Garabedian, CEO of Xontogeny is a finalist in the Contrarian category and LEO Science & Tech Hub in the Newcomer category.

The Xconomy Awards are part of the Biotech Week in Boston and will be presented at the awards gala on September 26th.

About LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 28 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients. In addition to clients listed above, LaVoieHealthScience represents leaders such as Cydan Development, Imara, NewLink Genetics, Biotechnology Innovation Organization, Newron Pharmaceuticals, Origenis, and other emerging health and science companies.

August is…. READER’S CHOICE

Catch up on some of your favorite LaVoieHealthScience blogs! They include, Infographics: No Longer If, But HowHow and When to Build a Board and Paper or Pixels? We’ll Take Both.

Infographics: No Longer If, But How

Infographics are no longer “if we have the time and budget,” but “how do we make ours inform and engage.” Engagement is increased markedly if a picture is included.  We took a deeper dive on why, which and how to use infographics.

How and When to Build a Board: A Primer for Emerging Companies

How many people, when to recruit and what kind of strategy to build a board for an emerging health science company?  We surveyed a few trusted board members  for advice on when to build a board, how to select board members and what size board to consider.

Paper or Pixels? We’ll Take Both

It’s one thing to be environmentally conscious, but another to give a presentation without any hard copy collateral. Read our thoughts on using a single-page fact sheet or copy of the slides to support the real-time presentation.

We hope you find these informational and fun to read! Visit our blog page here for other strategic communications insights.

You Say News Log, I Say Web Blog

We’ve been noodling about press releases and news lately – not just obvious, material news like quarterly financials or clinical data, but “almost” news like attendance at an invitation-only conference or re-appointment as an adjunct professorship.  “Obvious” news goes out on the wire as a press release, and is then posted to a company’s News page.  But what about less obvious news?  While there may not be a clear-cut need for a press release, there is a strong rationale for posting “lowercase” news on your company News page.  To be clear, publicly traded companies must disclose material news in a full-disclosure manner.  But both public and private companies may have lesser news that they choose to share.

The company News page: Your News page is akin to a blog that visitors can view for an “at-a-glance” understanding of the company’s activity. This channel can be used to share information that visitors would be interested in learning – for example, an op-ed penned by a member of the management team.   In other words, consider extending the use of your News page beyond that of a repository for wire service press releases.

Social media:  While social media allows for ongoing news distribution, the various channels are less helpful for “at-a-glance” insight due to limits on individual posts, yet unlimited cumulative posts.  Because traditional media came first, it is now a habit at most companies to pull press releases through their social channels.   There is an opportunity, however, to consider pulling some of the content from your social channels through to your News page.

Wire service press release:  When a piece of news is released over a wire service, a company believes that this is material information.  There is normally time, resources and a process in place for this type of news.  But utilizing an all-or-nothing, “it’s a press release or it’s not news” mindset can create an unnatural limit on what visitors to your News page can learn.

Providing up-to-date information is crucial to keeping your audiences in the loop.  While not all news may be worthy of wide distribution, providing updates on an ongoing basis is not only suitable, but also desirable.  Think broadly about your News page, as it can be used for wire service press releases and more, filling the role of an ongoing, cumulative forum for the company’s activities.

Donna LaVoie to Present “The LHS Fifteen-Slide Presentation®” at Venture Cafe

You’re Invited: “The LHS Fifteen-Slide Presentation®

Venture Café at The Cambridge Innovation Center (CIC)

Thursday, August 24, 5:30 – 6:30 p.m.

 

You are invited to join Donna LaVoie, President & CEO of LaVoieHealthScience, for her trademarked workshop “The LHS Fifteen-Slide Presentation®” on August 24 from 5:30-6:30 pm ET at the Venture Cafe, One Broadway, Kendall Square, Cambridge. First presented at BIO International in 2016, the workshop was offered again in 2017 to a standing-room-only crowd and is now available on the East Coast!

This workshop covers how to create an engaging company presentation in just 15 slides.   At this interactive session, attendees will learn:

  • The basics of a great presentation including slides to cover the science and business strategy
  • The qualities of a great presentation including how to be both succinct and specific

To prepare for the workshop, attendees can download and fill out the “Creating Your Elevator Pitch” worksheet by following the link below. This document is the first essential part of crafting effective presentation slides.

Please RSVP to Ryan Donovan, rdonovan@lavoiehealthscience.com

We look forward to seeing you.